SCHEMBL29469874

SCHEMBL29469874

CCOc1cccc(S(N)(=O)=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 12/20 0.62
CA2 P00918 12/20 0.62
CA9 Q16790 11/20 0.62
CA7 P43166 8/20 0.62
CA12 O43570 7/20 0.62
TTK P33981 1/20 0.56
MAPK8 P45983 1/20 0.56
TP53 P04637 1/20 0.55
CYP3A4 P08684 1/20 0.55
CA14 Q9ULX7 6/20 0.52
CA4 P22748 2/20 0.48
LMNA P02545 2/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
KAT6A Q92794 1/20 0.48
TSHR P16473 1/20 0.46
KDM4E B2RXH2 1/20 0.46
CA3 P07451 1/20 0.46
PKM P14618 1/20 0.46
CA6 P23280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5610159 1.00 CA1 (0.62) CA1CA2CA9CA7CA12
SCHEMBL9058916 0.85 TP53 (0.53) CA1CA2CA9CA7CA12
SCHEMBL3936854 0.85 CA1 (0.68) CA1CA2CA9CA7CA12
SCHEMBL14773591 0.84 TP53 (0.52) CA1CA2CA9CA7CA12
SCHEMBL13592998 0.84 TP53 (0.52) CA1CA2CA9CA7CA12
SCHEMBL3492741 0.82 KAT6A (0.51) CA1CA2CA9CA7CA12
SCHEMBL5610156 0.82 KAT6A (0.51) CA1CA2CA9CA7CA12
SCHEMBL3283827 0.82 TP53 (0.50) CA1CA2CA9CA7CA12
SCHEMBL24686632 0.81 KAT6A (0.50) CA1CA2CA9CA7CA12
SCHEMBL28236411 0.81 TP53 (0.49) CA1CA2CA9CA7CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
EP-4058439-A1 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY Genzyme Corporation (US) 2022-09-21 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed